Failure of interferon γ to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Nold Petry, Claudia A ^a,b   Lehrnbecher, Thomas ^a   Jarisch, Andrea ^a   Schwabe, Dirk ^a   Pfeilschifter, Josef M ^a   Muhl, Heiko ^a   Nold, Marcel F ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 27; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPHAGOCYTOSIS; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOPATHOGENESIS; INFANT; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION;

CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 77649267675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008663     Document Type: Article

References (38)

1. Farquhar JW, Claireaux AE (1952) Familial haemophagocytic reticulosis. Arch Dis Child 27: 519-525.
2. Caballes RL, Caballes-Ponce MG, Kim DU (1997) Familial hemophagocytic lymphohistiocytosis (FHLH). Pathology 29: 92-95.
3. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286: 1957-1959.
4. Busiello R, Adriani M, Locatelli F, Galgani M, Fimiani G, et al. (2004) Atypical features of familial hemophagocytic lymphohistiocytosis. Blood 103: 4610-4612.
5. Muralitharan S, Wali YA, Dennison D, Lamki ZA, Zachariah M, et al. (2007) Novel spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis in ethnic Omani patients. Am J Hematol 82: 1099-1102.
6. Cote M, Menager MM, Burgess A, Mahlaoui N, Picard C, et al. (2009) Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest.
7. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, et al. (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78: 2918-2922.
8. Ishii E, Ohga S, Aoki T, Yamada S, Sako M, et al. (1991) Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 85: 93-99.
9. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, et al. (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89: 4100-4103.
10. Dinarello CA (2007) Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 27: 98-114.
11. Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, et al. (2005) Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106: 3483-3489.
12. Takada H, Nomura A, Ohga S, Hara T (2001) Interleukin-18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma 42: 21-28.
13. Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, et al. (1999) Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol 106: 182-189.
14. Jordan MB, Hildeman D, Kappler J, Marrack P (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104: 735-743.
15. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, et al. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136.
16. Henter JI, Arico M, Egeler RM, Elinder G, Favara BE, et al. (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28: 342-347.
17. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, et al. (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100: 2367-2373.
18. Lehrnbecher T, Bernig T, Hanisch M, Koehl U, Behl M, et al. (2005) Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 19: 1745-1750.
19. Lehrnbecher T, Chanock SJ (2003) Detection of common cytokine and colony stimulating factor gene polymorphisms. Methods Mol Biol 215: 71-93.
20. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
21. Paulukat J, Bosmann M, Nold M, Garkisch S, Kampfer H, et al. (2001) Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol 167: 7038-7043.
22. Kaser A, Novick D, Rubinstein M, Siegmund B, Enrich B, et al. (2002) Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients. Clin Exp Immunol 129: 332-338.
23. Hurgin V, Novick D, Rubinstein M (2002) The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci U S A 99: 16957-16962.
24. Bachmann M, Paulukat J, Pfeilschifter J, Muhl H (2008) Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1/GAS axis on the promoter level. J Cell Mol Med.
25. Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, et al. (2009) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun.
26. Novick D, Elbirt D, Dinarello CA, Rubinstein M, Sthoeger ZM (2009) Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis. J Clin Immunol 29: 38-45.
27. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, et al. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 99: 61-66.
28. Sullivan KE, Delaat CA, Douglas SD, Filipovich AH (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 44: 465-468.
29. Katano H, Cohen JI (2005) Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 128: 739-750.
30. Hsieh SM, Chang SC (2006) Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol 176: 4530-4533.
31. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
32. Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, et al. (2005) Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol 86: 1121-1130.
33. Smith VP, Bryant NA, Alcami A (2000) Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 81: 1223-1230.
34. Tamura K, Kanazawa T, Tsukada S, Kobayashi T, Kawamura M, et al. (2008) Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 51: 662-668.
35. Kfoury Baz EM, Mikati AR, Kanj NA (2002) Reactive hemophagocytic syndrome associated with thrombotic thrombocytopenic purpura during therapeutic plasma exchange. Ther Apher 6: 159-162.
36. Kono T, Takigawa M, Nishimura F, Takashiba S, Nakagawa M, et al. (1997) Host defensive, immunological, and microbiological observations of an early-onset periodontitis patient with virus-associated hemophagocytic syndrome. J Periodontol 68: 1223-1230.
37. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, et al. (2003) Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170: 4886-4890.
38. Batten M, Ghilardi N (2007) The biology and therapeutic potential of interleukin 27. J Mol Med 85: 661-672.